Acute Promyelocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
651
|
21
|
0.600 |
None |
0.978 |
509 |
|
1990 |
2020 |
Osteitis Deformans
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
134
|
58
|
0.400 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.380 |
None |
1.000 |
8 |
|
1997 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.340 |
None |
1.000 |
5 |
|
2014 |
2019 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.330 |
None |
1.000 |
4 |
|
2009 |
2017 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.330 |
None |
1.000 |
4 |
|
2009 |
2017 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.310 |
None |
1.000 |
2 |
|
2004 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
143
|
29
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Giant Cell Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
95
|
3
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Treatment related secondary malignancy
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug-Induced Stevens Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
31
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Mycoplasma-Induced Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
30
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neoplasms, Second Primary
|
phenotype |
Neoplasms
|
Neoplastic Process
|
44
|
2
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stevens-Johnson Syndrome
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
67
|
16
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neoplasms, Therapy-Associated
|
phenotype |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
50
|
1
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Leukopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
440
|
153
|
0.120 |
None |
1.000 |
2 |
|
2018 |
2019 |
Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
389
|
97
|
0.110 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.110 |
None |
1.000 |
1 |
|
2005 |
2005 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.975 |
81 |
|
1995 |
2019 |